Colinz Laboratories Ltd
Colinz Laboratories (BSE)

24.05

10.99
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Colinz Laboratories Ltd stands at 9 against 9, three months back.

Colinz Laboratories Limited is an India-based company, which is engaged in the manufacturing and marketing of pharmaceutical formulations particularly in gynecological sector. The Company operates and supplies medicines in the domestic market. The Company’s products include oncology, ayurvedic and nutraceuticals. Its oncology products include imatinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, doxorubicin, filgrastim and pegylated liposome doxorubicin. Its ayurvedic products include anti-diarrheas, anti-pyrectics, anti-inflammatories, anti-spasmodic, cough syrups, appetite stimulating agents, memory boosters, anti-piles, antacids, liver tonic, ulcer healing agents, digestive agents, drugs to treat oligospermia and erectile dysfunction, ear drops, uterine tonic, anti-diabetics, and general tonics.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
27.21
100 DMA ()
27.18
200 DMA ()
25.48
52 Weeks Range
15.55
43.45
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity